Logo image of MNTK

MONTAUK RENEWABLES INC (MNTK) Stock Fundamental Analysis

NASDAQ:MNTK - Nasdaq - US61218C1036 - Common Stock

4.34  -0.15 (-3.34%)

Fundamental Rating

6

MNTK gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 21 industry peers in the Independent Power and Renewable Electricity Producers industry. MNTK has only an average score on both its financial health and profitability. MNTK is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make MNTK suitable for growth investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year MNTK was profitable.
In the past year MNTK had a positive cash flow from operations.
Of the past 5 years MNTK 4 years were profitable.
Each year in the past 5 years MNTK had a positive operating cash flow.
MNTK Yearly Net Income VS EBIT VS OCF VS FCFMNTK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 20M -20M 40M 60M 80M

1.2 Ratios

MNTK has a better Return On Assets (6.14%) than 90.00% of its industry peers.
The Return On Equity of MNTK (8.35%) is better than 75.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 8.48%, MNTK belongs to the top of the industry, outperforming 90.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for MNTK is above the industry average of 4.30%.
The 3 year average ROIC (7.03%) for MNTK is below the current ROIC(8.48%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.14%
ROE 8.35%
ROIC 8.48%
ROA(3y)4.43%
ROA(5y)3.5%
ROE(3y)6.33%
ROE(5y)5.13%
ROIC(3y)7.03%
ROIC(5y)5.5%
MNTK Yearly ROA, ROE, ROICMNTK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 5 10 15

1.3 Margins

The Profit Margin of MNTK (11.80%) is better than 65.00% of its industry peers.
In the last couple of years the Profit Margin of MNTK has declined.
Looking at the Operating Margin, with a value of 17.92%, MNTK is in the better half of the industry, outperforming 65.00% of the companies in the same industry.
MNTK's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 48.31%, MNTK perfoms like the industry average, outperforming 45.00% of the companies in the same industry.
In the last couple of years the Gross Margin of MNTK has declined.
Industry RankSector Rank
OM 17.92%
PM (TTM) 11.8%
GM 48.31%
OM growth 3Y53.81%
OM growth 5Y-14.87%
PM growth 3Y23.1%
PM growth 5Y-19.15%
GM growth 3Y6.08%
GM growth 5Y-3.85%
MNTK Yearly Profit, Operating, Gross MarginsMNTK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 10 20 30 40 50

More info and screens

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MNTK is destroying value.
Compared to 1 year ago, MNTK has more shares outstanding
The number of shares outstanding for MNTK has been increased compared to 5 years ago.
MNTK has a better debt/assets ratio than last year.
MNTK Yearly Shares OutstandingMNTK Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 50M 100M
MNTK Yearly Total Debt VS Total AssetsMNTK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

An Altman-Z score of 5.11 indicates that MNTK is not in any danger for bankruptcy at the moment.
The Altman-Z score of MNTK (5.11) is better than 95.00% of its industry peers.
MNTK has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
MNTK has a better Debt to Equity ratio (0.17) than 95.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z 5.11
ROIC/WACC0.95
WACC8.94%
MNTK Yearly LT Debt VS Equity VS FCFMNTK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 50M 100M 150M 200M 250M

2.3 Liquidity

MNTK has a Current Ratio of 2.04. This indicates that MNTK is financially healthy and has no problem in meeting its short term obligations.
MNTK's Current ratio of 2.04 is fine compared to the rest of the industry. MNTK outperforms 75.00% of its industry peers.
MNTK has a Quick Ratio of 2.04. This indicates that MNTK is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of MNTK (2.04) is better than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.04
Quick Ratio 2.04
MNTK Yearly Current Assets VS Current LiabilitesMNTK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 25.00% over the past year.
The earnings per share for MNTK have been decreasing by -12.06% on average. This is quite bad
The Revenue has grown by 9.63% in the past year. This is quite good.
MNTK shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.48% yearly.
EPS 1Y (TTM)25%
EPS 3Y51.91%
EPS 5Y-12.06%
EPS Q2Q%33.33%
Revenue 1Y (TTM)9.63%
Revenue growth 3Y20.32%
Revenue growth 5Y8.48%
Sales Q2Q%18.37%

3.2 Future

The Earnings Per Share is expected to grow by 10.29% on average over the next years. This is quite good.
The Revenue is expected to grow by 13.98% on average over the next years. This is quite good.
EPS Next Y90.4%
EPS Next 2Y17.35%
EPS Next 3Y21.31%
EPS Next 5Y10.29%
Revenue Next Year12.44%
Revenue Next 2Y21.64%
Revenue Next 3Y13.98%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MNTK Yearly Revenue VS EstimatesMNTK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 50M 100M 150M 200M 250M
MNTK Yearly EPS VS EstimatesMNTK Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.1 0.2 0.3

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 28.93 indicates a quite expensive valuation of MNTK.
Compared to the rest of the industry, the Price/Earnings ratio of MNTK indicates a somewhat cheap valuation: MNTK is cheaper than 65.00% of the companies listed in the same industry.
MNTK's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.29.
A Price/Forward Earnings ratio of 31.52 indicates a quite expensive valuation of MNTK.
70.00% of the companies in the same industry are more expensive than MNTK, based on the Price/Forward Earnings ratio.
MNTK is valuated rather expensively when we compare the Price/Forward Earnings ratio to 24.44, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 28.93
Fwd PE 31.52
MNTK Price Earnings VS Forward Price EarningsMNTK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MNTK is valued cheaper than 85.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.22
MNTK Per share dataMNTK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

MNTK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MNTK has a very decent profitability rating, which may justify a higher PE ratio.
MNTK's earnings are expected to grow with 21.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.32
PEG (5Y)N/A
EPS Next 2Y17.35%
EPS Next 3Y21.31%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MNTK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MONTAUK RENEWABLES INC

NASDAQ:MNTK (1/22/2025, 1:56:20 PM)

4.34

-0.15 (-3.34%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)11-12 2024-11-12/amc
Earnings (Next)N/A N/A
Inst Owners19.1%
Inst Owner Change0.05%
Ins Owners53.94%
Ins Owner Change0%
Market Cap622.23M
Analysts48.89
Price Target6.06 (39.63%)
Short Float %3.24%
Short Ratio7.1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-45.34%
Min EPS beat(2)-114.52%
Max EPS beat(2)23.84%
EPS beat(4)2
Avg EPS beat(4)-12.76%
Min EPS beat(4)-114.52%
Max EPS beat(4)96.08%
EPS beat(8)2
Avg EPS beat(8)-46.7%
EPS beat(12)2
Avg EPS beat(12)-45.95%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.87%
Min Revenue beat(2)-9.55%
Max Revenue beat(2)5.8%
Revenue beat(4)1
Avg Revenue beat(4)-9.6%
Min Revenue beat(4)-19.3%
Max Revenue beat(4)5.8%
Revenue beat(8)2
Avg Revenue beat(8)-12.39%
Revenue beat(12)4
Avg Revenue beat(12)-5.78%
Revenue beat(16)7
Avg Revenue beat(16)-2.76%
PT rev (1m)0%
PT rev (3m)-5.94%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-37.03%
EPS NY rev (1m)0%
EPS NY rev (3m)-6.66%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.71%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.15%
Valuation
Industry RankSector Rank
PE 28.93
Fwd PE 31.52
P/S 3.19
P/FCF N/A
P/OCF 9.64
P/B 2.26
P/tB 2.42
EV/EBITDA 11.22
EPS(TTM)0.15
EY3.46%
EPS(NY)0.14
Fwd EY3.17%
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)0.45
OCFY10.37%
SpS1.36
BVpS1.92
TBVpS1.79
PEG (NY)0.32
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.14%
ROE 8.35%
ROCE 10.42%
ROIC 8.48%
ROICexc 10.15%
ROICexgc 10.86%
OM 17.92%
PM (TTM) 11.8%
GM 48.31%
FCFM N/A
ROA(3y)4.43%
ROA(5y)3.5%
ROE(3y)6.33%
ROE(5y)5.13%
ROIC(3y)7.03%
ROIC(5y)5.5%
ROICexc(3y)10.13%
ROICexc(5y)7.44%
ROICexgc(3y)10.98%
ROICexgc(5y)8.04%
ROCE(3y)8.63%
ROCE(5y)6.76%
ROICexcg growth 3Y73.93%
ROICexcg growth 5Y-13.72%
ROICexc growth 3Y73.59%
ROICexc growth 5Y-13.71%
OM growth 3Y53.81%
OM growth 5Y-14.87%
PM growth 3Y23.1%
PM growth 5Y-19.15%
GM growth 3Y6.08%
GM growth 5Y-3.85%
F-Score8
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA 0.81
Cap/Depr 313.21%
Cap/Sales 36.45%
Interest Coverage 6.73
Cash Conversion 112.05%
Profit Quality N/A
Current Ratio 2.04
Quick Ratio 2.04
Altman-Z 5.11
F-Score8
WACC8.94%
ROIC/WACC0.95
Cap/Depr(3y)149.84%
Cap/Depr(5y)152.02%
Cap/Sales(3y)17.88%
Cap/Sales(5y)22.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25%
EPS 3Y51.91%
EPS 5Y-12.06%
EPS Q2Q%33.33%
EPS Next Y90.4%
EPS Next 2Y17.35%
EPS Next 3Y21.31%
EPS Next 5Y10.29%
Revenue 1Y (TTM)9.63%
Revenue growth 3Y20.32%
Revenue growth 5Y8.48%
Sales Q2Q%18.37%
Revenue Next Year12.44%
Revenue Next 2Y21.64%
Revenue Next 3Y13.98%
Revenue Next 5YN/A
EBIT growth 1Y23.58%
EBIT growth 3Y85.07%
EBIT growth 5Y-7.65%
EBIT Next Year104.37%
EBIT Next 3Y34.91%
EBIT Next 5Y15.25%
FCF growth 1Y-109.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-20.71%
OCF growth 3Y12.7%
OCF growth 5Y-3.74%